AngioDynamics, Inc.  

(Public, NASDAQ:ANGO)   Watch this stock  
Find more results for David A. Donnelly, Jr.�
10.28
+0.19 (1.88%)
Real-time:   1:15PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 10.08 - 10.31
52 week 9.71 - 19.33
Open 10.17
Vol / Avg. 16,226.00/109,999.00
Mkt cap 370.81M
P/E     -
Div/yield     -
EPS -0.17
Shares 36.29M
Beta 0.92
Inst. own 92%
Apr 7, 2016
Q3 2016 AngioDynamics Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jan 13, 2016
AngioDynamics Inc at JPMorgan Healthcare Conference - Webcast
Jan 7, 2016
Q2 2016 AngioDynamics Inc Earnings Call
Jan 7, 2016
Q2 2016 AngioDynamics Inc Earnings Release
Dec 2, 2015
AngioDynamics Inc at Piper Jaffray Healthcare Conference
Nov 19, 2015
AngioDynamics Inc at Canaccord Genuity Medical Technology & Diagnostics Forum
More events from DailyFinance »    

Key stats and ratios

Q4 (Nov '15) 2015
Net profit margin -0.41% -0.92%
Operating margin 1.48% -0.28%
EBITD margin - 13.42%
Return on average assets -0.19% -0.42%
Return on average equity -0.27% -0.60%
Employees 1,300 -
CDP Score - -

Address

14 Plaza Dr
LATHAM, NY 12110-2166
United States - Map
+1-518-7981215 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease, and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include fluid management, venous, thrombus management, as well as other core products. The Company's BioFlo products incorporate Endexo technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its microwave ablation products, its radiofrequency ablation (RFA) and its NanoKnife product lines.

Officers and directors

Howard W. Donnelly Independent Chairman of the Board
Age: 54
Bio & Compensation  - Reuters
Joseph M. DeVivo President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Michael Trimarchi Interim Chief Financial Officer, Vice President, Global Controller
Age: 35
Bio & Compensation  - Reuters
John J. Soto Executive Vice President, Chief Commercial Officer
Age: 51
Bio & Compensation  - Reuters
Gary Barrett Senior Vice President,Quality and Regulatory Affairs
Age: 47
Bio & Compensation  - Reuters
Ben Davis Senior Vice President, Business Development
Age: 51
Bio & Compensation  - Reuters
Barbara Kucharczyk Senior Vice President-Global Operations
Age: 42
Bio & Compensation  - Reuters
Mark A. Stephens Senior Vice President - Administration
Age: 47
Bio & Compensation  - Reuters
Stephen A. Trowbridge Senior Vice President, General Counsel
Age: 41
Bio & Compensation  - Reuters
David F. Burgstahler Independent Director
Age: 47
Bio & Compensation  - Reuters